09:54 AM EST - HLS Therapeutics Inc. : Announces that CEO Craig Millian, Chief Executive Officer, will present at H.C. Wainwright's 26th Annual Global Investment Conference, which takes place September 9-11, at the Lotte New York Palace Hotel in New York City. HLS Therapeutics Inc.
shares T.HLS are trading unchanged at $3.16.
